Delivery Order SPE2DB22D3011-SPE2DB25FQ2WM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed price contract valued at $2,770.27. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,052.07. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency has awarded a delivery order valued at $1,257.43 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100. This competitively awarded, firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract contains no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.22 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a child contract under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,358.09 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 12.5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by August 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $2,094.39. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,132.55 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the delivery of Ambien CR 6.25 mg tablets in quantities of 100 units. The order, with a firm fixed price structure and an ultimate completion date of September 24, 2025, represents a non-competitive award under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,852.14 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of August 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,559.10 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2WMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,129.49. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive contract portfolio with the Defense Logistics Agency covering a broad range of medications and medical supplies supporting military and veteran healthcare systems. The SPE2DX vehicle enables the company to supply pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order represents one of numerous transactions under this prime indefinite delivery vehicle, demonstrating the company's capability to fulfill federal procurement requirements through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |